简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2026-05-25 11:45 Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases
2026-05-25 11:35 BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts
2026-05-25 11:22 Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch
2026-05-25 11:20 Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis
2026-05-22 09:10 Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer
2026-05-22 09:08 SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend
2026-05-21 16:33 BeOne Medicines Launches One Save Changes Everything, a Global Cancer Care Awareness Campaign with Soccer Legend Tim Howard
2026-05-21 10:45 NordicTrack’s Most Ambitious Pilates Machine Yet: Introducing the Ultra 1 Reformer
2026-05-20 17:13 Chiesi Group Announces New Chair and Vice Chair
2026-05-20 09:55 Samsung Bioepis Launches Ustekinumab Biosimilar, Marking Its First Product Launch in Japan
2026-05-19 10:06 Oral‑B Announces The Big Rethink 2026, Launching One of Europe’s Largest Disability‑Focused Oral Health Studies
2026-05-18 14:16 Organon to Present New Research on Access and Value at ISPOR 2026
2026-05-15 11:17 BeOne Medicines’ BEQALZI™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell Lymphoma
2026-05-15 10:52 Amazfit Unveils the Cheetah 2 Ultra: The Performance Trail Running Watch Built to Master the Toughest Mountain Trails
2026-05-15 09:46 Medisca and dsm–firmenich Partner to Expand Access to Pharmaceutical-Grade Vitamin APIs for U.S. Compounding Market
2026-05-14 17:32 Aster Guardians Global Nursing Award Announces Top 10 Finalists for 2026
2026-05-14 14:54 Angelalign Technology Inc. (6699.HK) Applauds European Court Rejection of Patent Infringement Claim
2026-05-13 15:31 Takeda Announces FY2025 Full Year Results and FY2026 Outlook, Highlighted by Excellent Pipeline Progress and Solid FY2025 Results
2026-05-12 14:23 CORRECTING and REPLACING Samsung Epis Holdings Reports First Quarter 2026 Financial Results
2026-05-12 12:58 Fujirebio Announces CE Marking of the Fully Automated Lumipulse® G pTau 217 Plasma Assay

Business Wire Weibo

Press Releases

Latest Releases